CFDE Data Portal | Search TUBA3D

	Label	Description
	TUBA3D associations Collection (Entity type)	Associations for TUBA3D_associations
	TUBA3D associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	TUBA3D Gene (Entity type)	ENSG00000075886 - tubulin alpha 3d
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205976 GSE205978 CEP83 knockout TIME 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE240439 1 V 2 DECITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE168602 GSE168604 selumetinib COLO205 2 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

TUBA3D associations

Associations for TUBA3D_associations

TUBA3D associations.tsv

A file from IDG as part of the Harmonizome project

TUBA3D

ENSG00000075886 - tubulin alpha 3d

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE205976 GSE205978 CEP83 knockout TIME 1 v 4 human dn

A Gene Set from LINCS

GSE240439 1 V 2 DECITABINE HUMAN UP

A Gene Set from LINCS

GSE113655 phenol 5 v 4 human dn

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 1 v 2 human dn

A Gene Set from LINCS

GSE168602 GSE168604 selumetinib COLO205 2 v 6 human up

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.